A detailed history of Horizon Investments, LLC transactions in Incyte Corp stock. As of the latest transaction made, Horizon Investments, LLC holds 2,170 shares of INCY stock, worth $154,178. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,170
Previous 2,937 26.12%
Holding current value
$154,178
Previous $178,000 19.66%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$57.33 - $68.61 $43,972 - $52,623
-767 Reduced 26.12%
2,170 $143,000
Q2 2024

Aug 09, 2024

BUY
$51.18 - $63.75 $1,791 - $2,231
35 Added 1.21%
2,937 $178,000
Q1 2024

May 15, 2024

BUY
$56.55 - $66.59 $2,940 - $3,462
52 Added 1.82%
2,902 $165,000
Q4 2023

Feb 14, 2024

BUY
$52.16 - $64.19 $8,971 - $11,040
172 Added 6.42%
2,850 $178,000
Q3 2023

Nov 14, 2023

BUY
$57.77 - $65.93 $2,021 - $2,307
35 Added 1.32%
2,678 $154,000
Q2 2023

Aug 14, 2023

BUY
$60.95 - $75.51 $13,774 - $17,065
226 Added 9.35%
2,643 $164,000
Q1 2023

May 15, 2023

SELL
$70.23 - $86.01 $117,424 - $143,808
-1,672 Reduced 40.89%
2,417 $174,000
Q4 2022

Feb 14, 2023

BUY
$67.18 - $84.11 $11,958 - $14,971
178 Added 4.55%
4,089 $328,000
Q3 2022

Nov 14, 2022

BUY
$66.18 - $82.86 $40,965 - $51,290
619 Added 18.8%
3,911 $261,000
Q2 2022

Aug 12, 2022

BUY
$66.18 - $83.18 $217,864 - $273,828
3,292 New
3,292 $250,000
Q3 2020

Nov 16, 2020

SELL
$85.07 - $109.69 $275,626 - $355,395
-3,240 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$74.18 - $108.93 $240,343 - $352,933
3,240 New
3,240 $337,000
Q1 2020

May 15, 2020

SELL
$63.18 - $85.97 $216,517 - $294,619
-3,427 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$73.04 - $95.72 $250,308 - $328,032
3,427 New
3,427 $299,000
Q3 2019

Nov 14, 2019

SELL
$72.82 - $86.52 $522,920 - $621,300
-7,181 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$73.52 - $88.7 $527,947 - $636,954
7,181 New
7,181 $610,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.8B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Horizon Investments, LLC Portfolio

Follow Horizon Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Horizon Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Horizon Investments, LLC with notifications on news.